Pharmacological effects of Salvia miltiorrhiza (Danshen) on cerebral infarction

Chinese Medicine

Volumn 5, Issue , 2010, Pages

  Lin, Tsai Hui ^a   Hsieh, Ching Liang ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CRYPTOTANSHINONE; DIHYDROTANSHINONE; DRUG METABOLITE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GINKGO BILOBA EXTRACT; ISOPROPYL BETA (3,4 DIHYDROXYPHENYL) ALPHA HYDROXYPROPANOATE; MTB 70; ND 309; OXYGEN RADICAL; PANAX NOTOGINSENG EXTRACT; SALVIA MILTIORRHIZA EXTRACT; SALVIANOLIC ACID B; TANSHINONE; TANSHINONE I; TANSHINONE IIA; TANSHINONE IIB; UNCLASSIFIED DRUG; WARFARIN;

ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BRAIN EDEMA; BRAIN INFARCTION; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HYPERTENSION; NEUROLOGIC DISEASE; NONHUMAN; PLANT ROOT; SALVIA MILTIORRHIZA; THROMBOCYTE AGGREGATION; VASCULAR DISEASE;

EID: 77953665586     PISSN: None     EISSN: 17498546     Source Type: Journal    
DOI: 10.1186/1749-8546-5-22     Document Type: Article

References (60)

1. Dietl M, Pohle R, Weingärtner M, Polgar R, Grässel E, Schwab S, Kolominsky-Rabas P. Stroke etiology and long-term need of care in ischemic stroke patients. Fortschr Neurol Psychiatr 2009, 77(12):714-719. 10.1055/s-0028-1109912, 19950047.
2. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: American college of chest physicians evidence-based clinical practice guidelines. Chest 2008, 133(6):630S-669S. 8, 10.1378/chest.08-0720, 18574275.
3. Mostaza JM, Martín-Jadraque R, Vicente I, San Martin MA, Lahoz C. Patients at high risk of cerebrovascular disease: the REACH study. Cerebrovasc Dis 2009, 27(1):77-81. 10.1159/000200443, 19342835.
4. Liu LS, Caguioa ES, Park CG, Quek DKL, Saito I, Venketasubramanian N, Wong KSL, Reid JL. Reducing stroke risk in hypertensive patients: Asian Consensus Conference recommendations. Int J Stroke 2006, 1(3):150-157. 10.1111/j.1747-4949.2006.00041.x, 18706035.
5. Tuttolomondo A, Di Sciacca R, Di Raimondo D, Arnao V, Renda C, Pinto A, Licata G. Neuron protection as a therapeutic target in acute ischemic stroke. Curr Top Med Chem 2009, 9(14):1317-1334. 10.2174/156802609789869646, 19849659.
6. Kuang P, Wu W, Zhu K. Evidence for amelioration of cellular damage in ischemic rat brain by radix salviae miltiorrhizae treatment-immunocytochemistry and histopathology studies. J Tradit Chin Med 1993, 13(1):38-41. In Chinese.
7. Wu W, Kuang P, Li Z. Protective effect of radix Salviae miltiorrhizae on apoptosis of neurons during focal cerebral ischemia and reperfusion injury. J Tradit Chin Med 1997, 17(3):220-5. In Chinese.
8. Lao CJ, Lin JG, Kuo JS, Chiang SY, Chen SC, Liao ET, Hsieh CL. Effects of Salvia Miltiorrhiza Bunge on cerebral infarct in ischemia-reperfusion injured rats. Am J Chin Med 2003, 31(2):191-200. 10.1142/S0192415X03000916, 12856858.
9. Adams JD, Wang R, Yang J, Lien EJ. Preclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditions. Chin Med 2006, 1:3. 10.1186/1749-8546-1-3, 1761145, 17302964.
10. Zhou L, Zuo Z, Chow MSS. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 2005, 45(12):1345-59. 10.1177/0091270005282630, 16291709.
11. Chan TY. Interaction between warfarin and danshen (Salvia miltiorrhiza). Ann Pharmacother 2001, 35(4):501-504. 10.1345/aph.19029, 11302416.
12. Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009, 54(23):2129-2138. 10.1016/j.jacc.2009.09.009, 19942084.
13. Kang BY, Chung SW, Kim SH, Ryu SY, Kim TS. Inhibition of interleukin-12 and interferon-gamma production in immune cells by tanshinones from Salvia miltiorrhiza. Immunopharmacology 2000, 49(3):355-61. 10.1016/S0162-3109(00)00256-3, 10996033.
14. Chen YH, Lin SJ, Ku HH, Shiao MS, Lin FY, Chen JW, Chen YL. Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells. J Cell Biochem 2001, 82(3):512-21. 10.1002/jcb.1176, 11500927.
15. Ren DC, Du GH, Zhang JT. Inhibitory effect of the water-soluble extract of Salvia miltiorrhiza on neutrophil-endothelial adhesion. Jpn J Pharmacol 2002, 90(3):276-80. 10.1254/jjp.90.276, 12499583.
16. Zhang J, Yi S, Zhang X. Effects of salvia miltiorrhiza on hemorheological properties after brain injury. Chin J Neurosurg 1995, 11(1):784-790. In Chinese.
17. Fan GW, Gao XM, Wang H, Zhu Y, Zhang J, Hu LM, Su YF, Kang LY, Zhang BL. The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS. J Steroid Biochem Mol Biol 2009, 113(3-5):275-280. 10.1016/j.jsbmb.2009.01.011, 19429433.
18. Verma S, Badiwala MV, Weisel RD, Li SH, Wang CH, Fedak PWM, Li RK, Mickle DAG. C-reactive protein activates the nuclear factor-kappaB signal transduction pathway in saphenous vein endothelial cells: implications for atherosclerosis and restenosis. J Thorac Cardiovasc Surg 2003, 126(6):1886-1891. 10.1016/j.jtcvs.2003.07.026, 14688701.
19. Liang YJ, Shyu KG, Wang BW, Lai LP. C-reactive protein activates the nuclear factor-kappaB pathway and induces vascular cell adhesion molecule-1 expression through CD32 in human umbilical vein endothelial cells and aortic endothelial cells. J Mol Cell Cardiol 2006, 40(3):412-420. 10.1016/j.yjmcc.2005.12.008, 16430914.
20. Jang SI, Kim HJ, Kim YJ, Jeong SI, You YO. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways. Eur J Pharmacol 2006, 542(1-3):1-7. 10.1016/j.ejphar.2006.04.044, 16797002.
21. Fang ZY, Lin R, Yuan BX, Liu Y, Zhang H. Tanshinone IIA inhibits atherosclerotic plaque formation by down-regulating MMP-2 and MMP-9 expression in rabbits fed a high-fat diet. Life Sci 2007, 81(17-18):1339-1345. 10.1016/j.lfs.2007.08.043, 17942126.
22. Zhang Q, Chang Z, Yang J, Wang Q. Antiatherogenic property of triterpenoids-enriched extract from the aerial parts of Salvia miltiorrhiza. Phytother Res 2008, 22(8):1040-1045. 10.1002/ptr.2426, 18668491.
23. Kang DG, Yun YG, Ryoo JH, Lee HS. Anti-hypertensive effect of water extract of danshen on renovascular hypertension through inhibition of the renin angiotensin system. Am J Chin Med 2002, 30(1):87-93. 10.1142/S0192415X02000107, 12067101.
24. Tian S, Yu ZY, Tao F. Effects of Salvia miltiorrhizae renal intracasular injection to local angiotensin II in one-kidney, one clip hypertension rats. Chin J Integr Med 1996, 16:94-96. In Chinese.
25. Leung SWS, Zhu DY, Man RYK. Effects of the aqueous extract of Salvia Miltiorrhiza (danshen) and its magnesium tanshinoate B-enriched form on blood pressure. Phytother Res 2009, 24(5):769-774.
26. Kim DD, Sánchez FA, Durán RG, Kanetaka T, Durán WN. Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension. Am J Physiol Heart Circ Physiol 2007, 292(5):H2131-2137. 10.1152/ajpheart.01027.2006, 17172272.
27. Bednar MM, Gross CE. Antiplatelet therapy in acute cerebral ischemia. Stroke 1999, 30:887-893.
28. Terao S, Yilmaz G, Stokes KY, Russell J, Ishikawa M, Kawase T, Granger DN. Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemia-reperfusion. Stroke 2008, 39:2560-70. 10.1161/STROKEAHA.107.513150, 2748665, 18635850.
29. Jin X, Chen BL, Wu WJ, Gu Z, Jiang MH, Zhang ZH, Dong JC. Effects of eight danshensu's derivatives on rabbit platelet aggregation. J Shanghai Med Univ 2000, 27(3):181-184. In Chinese.
30. Wu YP, Zhao XM, Pan SD, Guo DA, Wei R, Han JJ, Kainoh M, Xia ZL, de Groot PG, Lisman T. Salvianolic acid B inhibits platelet adhesion under conditions of flow by a mechanism involving the collagen receptor alpha2beta1. Thromb Res 2008, 123(2):298-305. 10.1016/j.thromres.2008.05.020, 18625517.
31. Yao Y, Liu AH, Wu WY, Guan SH, Jiang BH, Yang M, Bi KS, Liu X, Guo DA. Possible target-related proteins of salvianolic acids in rat platelets. Phytochem Lett 2008, 1:135-138.
32. Wang X, Pang J, Shan C, Yang S, Zheng Y. Effect of danshen injection on pulmonary thromboembolism and platelet free radical levels in mice. Zhongguo Zhong Yao Za Zhi 1996, 21(9):558-560. In Chinese.
33. Wang Z, Zhang H, You H. Effect of danshen injection on pulmonary thromboembolism and platelet free radical levels in mice. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1994, 16(2):140-143. In Chinese.
34. Zhong P, Lin X. Effect of danshen injection on cytosolic free calcium concentration in normal rat platelet. Chin J Integr Surg 2005, 11(2):141-142. In Chinese.
35. Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT. Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J 2009, 276(1):13-26. 10.1111/j.1742-4658.2008.06766.x, 19087196.
36. Xia W, Han J, Huang G, Ying W. Inflammation in ischemic brain injury: current advances and future perspectives. Clin Exp Pharmacol Physiol 2009, 37(2):253-258. 10.1111/j.1440-1681.2009.05279.x, 19719754.
37. Korematsu K, Goto S, Nagahiro S, Ushio Y. Microglial response to transient focal cerebral ischemia: an immunochemical study on the rat cerebral cortex using anti-phosphotysine antibody. J Cereb Blood Flow Metab 1994, 14:825-830.
38. Morioka T, Kalehua AN, Streit WJ. The microglial reaction in the rat dorsal hippocampus following transient forebrain. J Cereb Blood Flow Metab 1991, 11:966-973.
39. Koo BS, Kwon TS, Kim CH. Salviae miltiorrhizae radix inhibits superoxide generation by activated rat microglia and mimics the action of amphetamine on in vitro rat striatal dopamine release. Neruochem Res 2004, 29(10):1837-1845.
40. Liu J, Kuang P, Li B, Wu W, Zhang F. Experiment studies on the mechanism of radix Salviae miltiorrhizae (RSM) induced neuroprection-reperfusion rats. Chin J Neuroimmol & Neurol 1998, 5(2):77-82. In Chinese.
41. Hu XM, Zhou MM, Hu XM, Wang J, Zeng FD. The effects of sodium β-aescinate on inflammatory process induced by focal cerebral ischemia-reperfusion in rats. Chin Pharmacol Bull 2006, 22(4):436-440. In Chinese.
42. Xu G, Zhao W, Zhou Z, Zhang R, Zhu W, Liu X. Danshen extracts decrease blood C reactive protein and prevent ischemic stroke recurrence: a controlled pilot study. Phytother Res 2009, 23(12):1721-1725. 10.1002/ptr.2819, 19449344.
43. Love S. Oxidative stress in brain ischemia. Brain Pathol 1999, 9(1):119-131.
44. Gursoy-Ozdemir Y, Can A, Dalkara T. Reperfusion -induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 2004, 35:1449-1453. 10.1161/01.STR.0000126044.83777.f4, 15073398.
45. Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 2001, 21:2-14. 10.1097/00004647-200101000-00002, 11149664.
46. Zhao GR, Zhang HM, Ye TX, Xiang ZJ, Yuan YJ, Guo ZX, Zhao LB. Characterization of the radical scavenging and anti-oxidant activities of danshensu and salvianolic acid B. Food Chem Toxicol 2008, 46:71-81.
47. Yu XY, Lin SG, Zhou ZW, Chen X, Liang J, Duan W, Yu XQ, Wen JY, Chowbay B, Li CG, Sheu FS, Chan E, Zhou SF. Tanshinone IIB, a primary active constituent from Salvia miltiorrhza, exhibits neuro-protective activity in experimentally stroked rats. Neurosci Lett 2007, 417(3):261-265. 10.1016/j.neulet.2007.02.079, 17397998.
48. Kuang P, Tao Y, Tian Y. Radix Salviae miltiorrhizae treatment results in decreased lipid peroxidation in reperfusion injury. J Tradit Chin Med 1996, 16(2):138-142. In Chinese.
49. Kuang P, Tao Y, Tian Y. Effect of radix Salviae miltiorrhizae on nitric oxide in cerebral ischemic-reperfusion injury. J Tradit Chin Med 1996, 16(3):224-227. In Chinese.
50. Tian J, Li G, Liu Z, Zhang S, Qu G, Jiang W, Fu F. ND-309, a novel compound, ameliorates cerebral infarction in rats by antioxidant action. Neurosci Lett 2008, 442(3):279-283. 10.1016/j.neulet.2008.07.033, 18652875.
51. Liu C, Min LQ, Ji ZS, W Q, Jia YJ, Li SY. Protective effects of Salvia miltiorrhizae on oxidative stress in rats with focal cerebral ischemia. Chin J Clin Rehabil 2006, 10(3):37-39. In Chinese.
52. Mo Z, Zheng Y, Pan Z, Liang R. Protective effect and mechanism of salvia miltiorrhiza on cerebral ischemia reperfusion injury in rats. Chin Herb Pharmacol Clin 1998, 14(4):24-26. In Chinese.
53. Cheng TO. Danshen: what every cardiologist should know about this Chinese herbal drug. Int J Cardiol 2006, 110:411-412. 10.1016/j.ijcard.2005.08.069, 16730816.
54. Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, Wells PS. Systemic overview of warfarin and its drug and food interactions. Arch Intern Med 2005, 165:1095-1106. 10.1001/archinte.165.10.1095, 15911722.
55. Wu WWP, Yeung JHK. Inhibition of warfarin hydroxylation by major tanshinones of Danshen (Salvia miltiorrhiza) in the rat in vitro and in vivo. Phytomedicine 2009, 17(3-4):219-226. 10.1016/j.phymed.2009.05.005, 19577456.
56. Cheng TO. Cardiovascular effectsof danshen. Int J Cardiol 2007, 121:9-12. 10.1016/j.ijcard.2007.01.004, 17363091.
57. Ellnain-Wojtaszek M, Kruczyński Z, Kasprak J. Investigation of the free radical scavenging activity of Ginkgo biloba L. leaves. Fitoterapia 2003, 74:1-6. 10.1016/S0367-326X(02)00306-4, 12628386.
58. Lee EJ, Chen HY, Wu TS, Chen TY, Ayoub IA, Kenneth I, Maynard MJ. Acute administration of Ginkgo biloba extract (EGb761) affords neuroprotection against permanent and transient focal cerebral ischemia in Spragrue-Dawley rats. J Neurosci Res 2002, 68:636-645. 10.1002/jnr.10251, 12111854.
59. CS L, Cheng Y, Hu JF, Zhang W, Chen NH, Zhang JT. Comparison of antioxidant activities between salvianolic acid B and Ginkgo biloba extract (EGb 761). Acta Pharmacol Sin 2006, 27(9):1137-1145. 10.1111/j.1745-7254.2006.00378.x, 16923333.
60. Zhao GR, Xiang ZJ, Ye TX, Yuan YJ, Guo ZX. Antioxidant activities of Salvia miltiorrhiza and Panax notoginseng. Food Chem 2006, 99:767-774.